# LifeMD, Inc. (LFMD) · Edgar & Edgarette company card

> LifeMD (LFMD) grew revenue 25.3% in FY2025 to $194 million, operating margin -4.0% against a 2.0% median for offices & clinics of  doctors of  medicine, equity 32.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 948320 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/LFMD) · [JSON](https://www.pops4.com/boards/company/LFMD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $194M |
| Revenue growth, 1 year | 25.3% |
| Revenue growth per year | 20.2% |
| Operating margin | -4.0% (prior year -13.2%) |
| Net margin | 8.0% |
| Operating cash flow | $8M |
| Capital spending | $2M |
| Free cash flow | $6M |
| Cash | $37M |
| Long-term debt | — |
| Total assets | $70M |
| Total equity | $23M |
| Equity ÷ assets | 32.9% |
| Return on equity | 67.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -9.85 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · filed late quarterly report notice in the last 12 months; operating loss: a margin of -4.0% in FY2025
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $194.1M (FY2025). Experience: revenue up 25.3% on the year, up 20.2% a year over 4 years; operating margin -4.0%, up from -13.2%. Soundness: equity 32.9% of assets, return on equity 67.5%, payout 19.9% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $193.7M and $276.0M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $177.2M to $303.0M. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): operating margin -4.0% against a 2.0% median; growth 25.3% against 13.0%.

Range logged 2026-09-29, receipt a3c4eadc17fc49f9, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-Q Late quarterly report notice: 1, latest 2025-11-12 ([filing](https://www.sec.gov/Archives/edgar/data/948320/000149315225022009/0001493152-25-022009-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-03-18 ([filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226011228/0001493152-26-011228-index.htm))

## Recent filings

- 8-K · filed 2026-09-15 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226042691/0001493152-26-042691-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226036200/0001493152-26-036200-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226036170/0001493152-26-036170-index.htm)
- 8-K · filed 2026-06-22 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226029503/0001493152-26-029503-index.htm)
- 10-Q · filed 2026-05-06 · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226021536/0001493152-26-021536-index.htm)
- 8-K · filed 2026-05-06 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/948320/000149315226021520/0001493152-26-021520-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000948320.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=948320

## Cite

POPS4, Edgar & Edgarette: LifeMD, Inc. (LFMD) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/LFMD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.